Terra Catalyst Fund

TheraCryf plc is a clinical stage therapeutics company developing a new generation of innovative therapeutics in oncology and behavioural brain disorders. TheraCryf’s strategy is to generate compelling data sets with a goal of partnering its programmes with mid-size to large pharma. TheraCryf’s leadership team has decades of corporate, financial and scientific experience in biotech and pharma companies and is supported by an expert Scientific Advisory Board. TheraCryf: Turner Pope Jun 3, 2025